Effect of Intravenous Morphine and Ketorolac on Pain Control in Long Bones Fractures
Babak Masoumi, Behdad Farzaneh, Omid Ahmadi, Farhad Heidari
Department of Emergency Medicine, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Web Publication||28-Jul-2017|
Department of Emergency Medicine, Medical School, Isfahan University of Medical Sciences, Isfahan
Source of Support: None, Conflict of Interest: None
Background: According to the lack of adequate studies on comparing the analgesic effect and complications of ketorolac with morphine in long bone fractures, this study aimed to compare the efficacy of ketorolac with morphine in patients referring to the Emergency Department with long bones damage and fracture. Materials and Methods: In this clinical trial study, 88 patients with long bone fracture were selected randomly and divided into two groups. To scale the intensity of pain, visual analog scale (VAS) were used. Intravenous ketorolac and morphine with the loading dose of 10 mg and 5 mg, respectively was administered to a group, followed by 5 mg and 2.5 mg every 5–20 min, if necessary (VAS ≥4). The pain scores before injection and at 5 min, half an hour and 1-h after the injection were measured and recorded for all patients. Results: The mean age of the ketorolac and morphine groups was 29.1 ± 12.5 and 33.2 ± 11.4, respectively. In the groups, there was 63.6% and 70.5% of male patients respectively. The mean ± SD of pain score before the injection was 7.59 ± 1 and 7.93 ± 1.09 (P = 0.13). One hour after the injection, the mean ± SD of pain in the both groups was 1.41 ± 0.9 and 1.61 ± 1.17 and the mean pain score has no significant difference in the two groups before the injection. Repeated measures ANOVA test also showed that the trend of changes in pain score had no significant difference in both groups (P = 0.08). Conclusion: According to the fewer side effects of ketorolac and effective pain release versus morphine, ketorolac could be suggested to use.
Keywords: Ketorolac, long bone fracture, morphine
|How to cite this article:|
Masoumi B, Farzaneh B, Ahmadi O, Heidari F. Effect of Intravenous Morphine and Ketorolac on Pain Control in Long Bones Fractures. Adv Biomed Res 2017;6:91
|How to cite this URL:|
Masoumi B, Farzaneh B, Ahmadi O, Heidari F. Effect of Intravenous Morphine and Ketorolac on Pain Control in Long Bones Fractures. Adv Biomed Res [serial online] 2017 [cited 2020 May 29];6:91. Available from: http://www.advbiores.net/text.asp?2017/6/1/91/211832
| Introduction|| |
Pain is one of the major causes of referring to Emergency Department with a remarkable number of main complaints. Although pain is the most common complaint of patients in Emergency Department, few studies have been conducted on the prevalence of the issue. In the previous studies, the study populations were heterogeneous, and we do not have enough information on the prevalence of patients with long bone fractures referring to Emergency Department.,,,
One of the major causes of pain is trauma, which is defined as the damage caused by external or internal forces of the body and can be associated with either the loss of continuity of structures or not.,,,, Studying and treatment of pain has for a long time been one of the grounds neglected by the modern medicine. Several studies have shown that a lot of people referring to Emergency Department, especially children, and trauma victims received treatment less than what is needed for the pain. There are many barriers including racial and ethnic issues, pain tolerance, and the inadequate knowledge of emergency medical personnel on the adequate and appropriate pain management in Emergency Department.,,,
Morphine is the most common analgesic used for pain control in these patients. Although such analgesics are cheap, the risk of dependency is existed; therefore, they are regarded as dangerous drugs. Divided and repeated doses of morphine results in dependency and it's unite do can result in serious complications, so it increases the need for monitoring the patient by medical staff and personnel. Another problem of morphine and other opioids is to have the sedative property that makes the patient completely unconscious. In addition to better pain relief, high doses of opioids have more side complications and, in fact, they are like a double-edged sword.,, Ketorolac as a nonsteroidal anti-inflammatory injected drug (NSAID) has analgesic and anti-inflammatory properties. Also, it does not have sedative property. It is only as an injectable NSAID allow to control the pain as a rapid intravenous injection in North America, UK and other parts of Europe and Hong Kong. Several studies have suggested that ketrolac can be compared in the treatment of acute pain with opioids.
Given the properties of ketorolac, as an NSAID, and the lack of enough studies regarding the comparison between analgesic effect and complications of ketorolac with morphine in long bone fractures, the present study aimed to compare the efficacy of ketorolac with morphine in patients referring to the Emergency Department due to the long bones damage and fracture.
| Materials and Methods|| |
This is a double-blind clinical trial study conducted in June 2013 to September 2014 on patients referring to Emergency Department of Al-Zahra Hospital due to long bone fractures. This study was approved by Local Ethic Committee of Isfahan University of Medical Sciences, and all patients signed a consent form.
Eighty-eight patients were randomly divided into two groups (morphine and ketorolac group) by block randomization in a way that the first patient was luckily put in the morphine group and the others were successively and alternatively distributed in the ketorolac and morphine groups. Inclusion criteria were age over 18 years, patient's consent to participate in the study, patients with long bones fractures, and without asthma, chronic obstructive pulmonary disease, rheumatoid fever, peptic ulcer disease, gastrointestinal bleeding (GIB), and known hypersensitivity to drugs. It should be noted that patients with other problems except long bone fractures, patients without complete consciousness, as well as patients with hemodynamic instability and symptoms of respiratory depression and GIB during the pain relief injection, were excluded from the study.
The required sample size was calculated using estimating sample size formula as a total of 44 patients assigned to each group, to compare two means and considering 95% of confidence level, test power of 80, postoperative pain score of 1.33 and 0.8 as minimal significant difference between the two groups (See flow digram).
The blind method was in a way that patients were unaware of the type of drug and injection was performed by the physician of project manager while the pain score assessment was done by a nurse in the Emergency Department who was not aware about the study.
At first the patients were evaluated in terms of inclusion and exclusion criteria and then, interviewed by emergency medicine resident; their pain score was assessed by visual analog scale (VAS) scale too., In the procedure, intravenous ketorolac with the loading dose of 10 mg was administered to a group within 60 s, followed by 5 mg every 5 min to 20 min, if necessary (VAS ≥4) and intravenous morphine with the loading dose 5 mg was administered to another group, followed by 2.5 mg every 5 min to 20 min, if necessary(VAS ≥4). The pain scores before the injection and at 5 min, half and 1 h after the injection were measured and recorded for all patients.
Finally, the obtained data were analyzed by SPSS software version 22 (SPSS Inc, Chicago, IL, USA) using statistical Chi-square for comparing the individual and nominal variables between groups and Student's t-tests in order to compare the ordinal variables.
| Results|| |
In this study, 88 patients with regard to the inclusion criteria of the study were distributed and studied in two groups of 44 individuals.
The mean of age in the two groups receiving morphine and ketorolac was 33.18 ± 11.4 and 29.1 ± 12.5, respectively and according to t-test, there was no significant difference between the two groups (P = 0.11). The sex ratio (female/male) was 31.13 and 28.16, respectively in the two groups of receiving morphine and ketorolac and according to Chi-square test there was no significant difference between the two groups (P = 0.5). Generally, the most common type of fracture was radius bone fracture and no significant difference was observed between the two groups (P = 0.91). The distribution of demographic variables and the type of fractures in the two groups are given in [Table 1].
|Table 1: Distribution of frequency of age, sex, and type of fracture in both groups|
Click here to view
The mean and standard deviation of pain score before the injection until 1-h after injection in both groups of morphine and ketorolac have been shown in [Table 2]. According to the t-test, the mean pain score has no significant difference in the two groups before the injection. The pain score did not differ at 5, 30, and 60 min after injection in both groups too. Repeated ANOVA also showed that the trend of changes in pain score had no significant difference in both groups (P = 0.08).
|Table 2: Mean and SD of pain score and the number of patients received additional dose of analgesics in the two groups|
Click here to view
During the study, 22 patients received the additional dose of drug wherein 14 individuals belonged to the morphine group and 8 ones to the ketorolac group (31.8% vs. 18.2%); however, according to Chi-square test, the receipt of additional dose of analgesic was not significantly different in the two groups (P = 0.11).
The frequency of receiving additional dose of analgesic in the both groups has been shown in [Figure 1]. In the following of [Table 2], the receipt frequency of additional dose of analgesic has been shown for the two groups from 5 to 20 min. According to Chi-square test, the frequency of additional dose of analgesic had a significant difference just at 10th min between the two groups (P = 0.021). Also, 20 min later, no patient has received an additional dose of analgesics.
|Figure 1: Distribution of the frequency of additional dose of analgesic in the two groups|
Click here to view
During the study, 22 patients suffered from postoperative complications as 18 cases were in the control group and 4 ones in the ketorolac group [Figure 2] (40.9% vs. 9.1%) and according to Chi-square test, incidence of complications had a significant difference in both groups (P = 0.001). The observed complications in patients included nausea, vomiting, dyspnea, and hypotension in 11, 3, 2, and 3 cases, respectively that according to the Fisher's exact test, the incidence of nausea had a significant difference in both groups (P = 0.024) [Table 3].
|Table 3: Frequency distribution of incidence of side complications in both groups|
Click here to view
| Discussion|| |
The overall objective of this study was to compare the effect of intravenous ketorolac and morphine on the control of pain in patients with long bone fractures admitted to Al-Zahra Hospital Emergency Department in Isfahan. In the present study, 44 patients with fractures in the mentioned parts received intravenous morphine and ketorolac injections and the pain relief, need to receive additional analgesic and the incidence of side complications from taking drug were compared in both groups.
Patients are receiving morphine and ketorolac had no significant difference in terms of age, sex and location of the fracture, and no distortive effect of these factors was found in both groups. According to the obtained results, with the intravenous injection of the first dose of the drug, the pain score was significantly reduced in both groups; however, pain reduction rate was the same in the two groups and no advantage was observed in the comparison between morphine and ketorolac. During the study, the morphine and ketorolac groups received 31.8% and 18.2% additional dose of analgesic, respectively; however, no statistically significant difference was observed between the two groups. Also, the total number of receiving analgesic times was not different in the two groups; however, at 10th min, more patients in the morphine group received additional analgesic. Therefore, taking morphine and ketorolac is equally effective in fracture pain reduction in patients with long bone fractures; however, the incidence rate of side complications was significantly higher in patients receiving morphine that the major difference was in the incidence of nausea after the intravenous injection of the drug.
In several studies, ketorolac has been compared with other analgesics. In the study conducted by Veenema et al., a single dose of ketorolac could be equal to meperidine while the side complications of ketorolac were less than that of meperidine. The study by Innes et al. which aimed to examine the side complications and effectiveness of ketorolac in the treatment of a low backache compared with acetaminophen-codeine concluded that ketorolac was the superior drug than acetaminophen codeine. In a study by Etches et al. with the aim of investigate the relief effect of ketorolac after the orthopedic surgeries, they concluded that an intravenous dose of ketorolac causes the reduction of morphine consumption and better relief in comparison with placebo. In a study by Rainer et al., the cost-effectiveness of intravenous ketorolac was compared with that of intravenous morphine in the treatment of pain in organ damage. The results revealed that compared to morphine, ketorolac is more cost-effective in pain relief in organ damage. However, in the study by Cepeda et al., in abdominal surgeries, the intravenous ketorolac alone had no sufficient performance in the pain relief despite the good tolerance by patients. Therefore, considering the important role of inflammatory mediators in the creation of pain and a lot of side complications of opioids, with appropriate anti-inflammatory properties and fewer side complications, ketorolac is an appropriate choice for pain reduction in patients with long bone fractures. This study had small sample size due to the inclusion criteria and unsatisfied patients refusing to participate and not including to the study samples which should be considered as a limitation.
Especially, in cases where taking opioids has the possibility to create complications, ketorolac is an appropriate analgesic and can be used depending on the physician discretion and patient's condition.
Financial support and sponsorship
Isfahan University of Medical Sciences.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Berben SA, Meijs TH, van Dongen RT, van Vugt AB, Vloet LC, Mintjes-de Groot JJ, et al.
Pain prevalence and pain relief in trauma patients in the accident and emergency department. Injury 2008;39:578-85.
Etches RC, Warriner CB, Badner N, Buckley DN, Beattie WS, Chan VW, et al.
Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty. Anesth Analg 1995;81:1175-80.
Purday JP, Reichert CC, Merrick PM. Comparative effects of three doses of intravenous ketorolac or morphine on emesis and analgesia for restorative dental surgery in children. Can J Anaesth 1996;43:221-5.
Stalnikowicz R, Mahamid R, Kaspi S, Brezis M. Undertreatment of acute pain in the emergency department: A challenge. Int J Qual Health Care 2005;17:173-6.
Cepeda MS, Vargas L, Ortegon G, Sanchez MA, Carr DB. Comparative analgesic efficacy of patient-controlled analgesia with ketorolac versus morphine after elective intraabdominal operations. Anesth Analg 1995;80:1150-3.
Innes GD, Croskerry P, Worthington J, Beveridge R, Jones D. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med 1998;16:549-56.
Mader TJ, Ames A, Letourneau P. Pain management in paediatric trauma patients with long bone fracture. Injury 2006;37:61-5.
Rainer TH, Jacobs P, Ng YC, Cheung NK, Tam M, Lam PK, et al.
Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: Double blind randomised controlled trial. BMJ 2000;321:1247-51.
Bijur P, Bérard A, Esses D, Calderon Y, Gallagher EJ. Race, ethnicity, and management of pain from long-bone fractures: A prospective study of two academic urban emergency departments. Acad Emerg Med 2008;15:589-97.
Petrack EM, Christopher NC, Kriwinsky J. Pain management in the emergency department: Patterns of analgesic utilization. Pediatrics 1997;99:711-4.
O'Connor AB, Zwemer FL, Hays DP, Feng C. Intravenous opioid dosing and outcomes in emergency patients: A prospective cohort analysis. Am J Emerg Med 2010;28:1041-50.e6.
Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med 2000;18:404-7.
Roberts, JR. Roberts and Hedges' Clinical Procedure in Emergency Medicine. 6th
ed. Philadelphia: Elsevier health sciences; 2014. p. 1521.
Marx JA, Hackberger RS, Walls RM. Rosen's Emergency Medicine Concepts and Clinical Practice. 8th
ed. Pennsylvania; SAUNDERS; 2014. p. 2521.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting
| ||Diana M. Sobieraj,Brandon K. Martinez,Benjamin Miao,Mark X. Cicero,Richard A. Kamin,Adrian V. Hernandez,Craig I. Coleman,William L. Baker |
| ||Prehospital Emergency Care. 2019; : 1 |
|[Pubmed] | [DOI]|
||Endogenous Opiates and Behavior: 2017
| ||Richard J. Bodnar |
| ||Peptides. 2019; : 170223 |
|[Pubmed] | [DOI]|
||Separation of Ketorolac enantiomers on polysaccharide-based chiral stationary phases using a polar organic mobile phase
| ||Yunchao He,Yaling Wu,Lingping Cheng,Shanshan He,Qiuhua Wang,Huiying Wang,Yanxiong Ke |
| ||Separation Science Plus. 2018; 1(5): 351 |
|[Pubmed] | [DOI]|